KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Elena Vendramini, Riccardo Bomben, Federico Pozzo, Dania Benedetti, Tamara Bittolo, Francesca Maria Rossi, Michele Dal Bo, Kari G. Rabe, Gabriele Pozzato, Francesco Zaja, Annalisa Chiarenza, Francesco Di Raimondo, Esteban D Braggio, Sameer A Parikh, Neil Elliot Kay, Tait D. Shanafelt, Giovanni Del Poeta, Valter Gattei, Antonella Zucchetto

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalLeukemia
DOIs
StatePublished - Jan 1 2019

Fingerprint

Trisomy
B-Cell Chronic Lymphocytic Leukemia
Mutation

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival. / Vendramini, Elena; Bomben, Riccardo; Pozzo, Federico; Benedetti, Dania; Bittolo, Tamara; Rossi, Francesca Maria; Dal Bo, Michele; Rabe, Kari G.; Pozzato, Gabriele; Zaja, Francesco; Chiarenza, Annalisa; Di Raimondo, Francesco; Braggio, Esteban D; Parikh, Sameer A; Kay, Neil Elliot; Shanafelt, Tait D.; Del Poeta, Giovanni; Gattei, Valter; Zucchetto, Antonella.

In: Leukemia, 01.01.2019.

Research output: Contribution to journalLetter

Vendramini, E, Bomben, R, Pozzo, F, Benedetti, D, Bittolo, T, Rossi, FM, Dal Bo, M, Rabe, KG, Pozzato, G, Zaja, F, Chiarenza, A, Di Raimondo, F, Braggio, ED, Parikh, SA, Kay, NE, Shanafelt, TD, Del Poeta, G, Gattei, V & Zucchetto, A 2019, 'KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival', Leukemia. https://doi.org/10.1038/s41375-019-0444-6
Vendramini, Elena ; Bomben, Riccardo ; Pozzo, Federico ; Benedetti, Dania ; Bittolo, Tamara ; Rossi, Francesca Maria ; Dal Bo, Michele ; Rabe, Kari G. ; Pozzato, Gabriele ; Zaja, Francesco ; Chiarenza, Annalisa ; Di Raimondo, Francesco ; Braggio, Esteban D ; Parikh, Sameer A ; Kay, Neil Elliot ; Shanafelt, Tait D. ; Del Poeta, Giovanni ; Gattei, Valter ; Zucchetto, Antonella. / KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival. In: Leukemia. 2019.
@article{935377cfc3b648ab93d7daaad7324771,
title = "KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival",
author = "Elena Vendramini and Riccardo Bomben and Federico Pozzo and Dania Benedetti and Tamara Bittolo and Rossi, {Francesca Maria} and {Dal Bo}, Michele and Rabe, {Kari G.} and Gabriele Pozzato and Francesco Zaja and Annalisa Chiarenza and {Di Raimondo}, Francesco and Braggio, {Esteban D} and Parikh, {Sameer A} and Kay, {Neil Elliot} and Shanafelt, {Tait D.} and {Del Poeta}, Giovanni and Valter Gattei and Antonella Zucchetto",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41375-019-0444-6",
language = "English (US)",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

AU - Vendramini, Elena

AU - Bomben, Riccardo

AU - Pozzo, Federico

AU - Benedetti, Dania

AU - Bittolo, Tamara

AU - Rossi, Francesca Maria

AU - Dal Bo, Michele

AU - Rabe, Kari G.

AU - Pozzato, Gabriele

AU - Zaja, Francesco

AU - Chiarenza, Annalisa

AU - Di Raimondo, Francesco

AU - Braggio, Esteban D

AU - Parikh, Sameer A

AU - Kay, Neil Elliot

AU - Shanafelt, Tait D.

AU - Del Poeta, Giovanni

AU - Gattei, Valter

AU - Zucchetto, Antonella

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85063040196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063040196&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0444-6

DO - 10.1038/s41375-019-0444-6

M3 - Letter

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -